Boothbay Fund Management, LLC Celldex Therapeutics, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $2.89 Million - $4.02 Million	90,200 New	90,200 $3.06 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $776,950 - $1.41 Million	37,900 Added 98.96%	76,200 $2.05 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $613,608 - $872,904	-22,200 Reduced 36.69%	38,300 $1.31 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $685,056 - $1.08 Million	-19,200 Reduced 24.09%	60,500 $2.34 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $341,610 - $660,682	11,800 Added 17.38%	79,700 $4.3 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $1.41 Million - $2.4 Million	67,900 New	67,900 $2.27 Million

203

66.1M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.19B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.